4//SEC Filing
Watson Robert Eugene 4
Accession 0001236031-20-000023
CIK 0000725363other
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 5:05 PM ET
Size
6.1 KB
Accession
0001236031-20-000023
Insider Transaction Report
Form 4
CEL SCI CORPCVM
Watson Robert Eugene
Director
Transactions
- Award
Options
2020-04-20$0.01/sh+128,000$1,280→ 378,000 totalExercise: $10.93Exp: 2030-04-19→ Common Stock (128,000 underlying)
Footnotes (1)
- [F1]These stock options are performance based. Each option entitles the holder to purchase one share of the Company's common stock at a price of $10.93 per share. The stock options vest upon the achievement of the following performance goals: i) 25% of the options will vest when the closing price of the Company's common stock exceeds $20.00 for ten consecutive trading days; ii) 50% of the options will vest when the closing price of the Company's common stock exceeds $25.00 for ten consecutive trading days; iii) 75% of the options will vest when the closing price of the Company's common stock exceeds $30.00 for ten consecutive trading days; and iv) 100% of the options will vest when either (a) the filing of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia or (b) the closing price of the Company's common stock exceeds $40.00 for ten consecutive trading days.
Documents
Issuer
CEL SCI CORP
CIK 0000725363
Entity typeother
Related Parties
1- filerCIK 0001511858
Filing Metadata
- Form type
- 4
- Filed
- Apr 19, 8:00 PM ET
- Accepted
- Apr 20, 5:05 PM ET
- Size
- 6.1 KB